Artificial Liver Leads the Way as New Life-Saver

Artificial Liver Leads the Way as New Life-Saver

Gastroenterology January 12, 2015 at 10:07 AM 0 comments

BIOARTIFICIAL livers could possess the ability to sustain liver failure (LF) patients until their own internal organs can repair themselves or a matching donor is found. For many end-stage liver disease (ESLD) and acute LF patients, transplantation is their final hope. Yet amazingly, only 3,000 organs are available for aRead More

Could New Cure Conquer Crohn’s in 2015?

Could New Cure Conquer Crohn’s in 2015?

Gastroenterology January 12, 2015 at 10:03 AM 0 comments

SUFFERERS of Crohn’s disease (CrD) worldwide could potentially be one step away from reaping the benefits of a cure for their condition, changing lives on a global scale. Prof John Hermon-Taylor, Visiting Professor, King’s College London, London, UK, who has spent the last 30 years dedicating his life to findingRead More

Liver Cancer Menace May Lie in Surrounding Immunity

Liver Cancer Menace May Lie in Surrounding Immunity

Hepatology January 6, 2015 at 9:34 AM 0 comments

MACROPHAGES may constitute the next target for liver cancer treatment as the presence of epidermal growth factor receptor (EGFR) in the cells surrounding tumour cells have been shown to catalyse tumour proliferation. Several years ago EGFR was found to occupy and promote the development of up to 70% of totalRead More

Gene Culprit behind Metabolic Syndrome Revealed

Gene Culprit behind Metabolic Syndrome Revealed

Hepatology January 6, 2015 at 9:23 AM 0 comments

HEALTHY gut microbiota may be the key to tackling metabolic syndrome (MetS); when a particular gene, known as Toll-like receptor 5 (TLR5), is absent from the intestinal surface then there is a significant change in bacteria that results in inflammation, catalysing MetS onset. The key to preventing this incidence, andRead More

New Oncotype DX® Data Presented at 2014 San Antonio Breast Cancer Symposium Further Demonstrate the Practice-Changing Impact of the Test in Guiding the Treatment of Early Stage Breast Cancer

Uncategorized December 16, 2014 at 9:27 AM 0 comments

 First prospective outcomes data reinforce the Oncotype DX test’s unique value in informing treatment decisions  Positive results of second large, independent validation study in DCIS breast cancer  GENEVA, Switzerland, [December 15, 2014] – Genomic Health announced presentation of the first prospective outcomes data from a large adjuvant study with theRead More

Gilead Presents Follow-Up Data from Idelalisib (Zydelig®) Registrational Studies in Patients with Chronic Lymphocytic Leukemia, Follicular Lymphoma and Small Lymphocytic Lymphoma

Uncategorized December 11, 2014 at 11:33 AM 0 comments

– Results Describing Long-Term Safety and Disease Control Presented at the 56th American Society of Hematology Annual Meeting – San Francisco, December 10, 2014 – Gilead Sciences, Inc. (Nasdaq: GILD) today announced long-term follow-up results from the registration studies further describing the duration of response, progression-free survival (PFS) and the safety profileRead More

Gilead Presents Follow-Up Data from Zydelig Registrational Studies in Patients with Chronic Lymphocytic Leukemia, Follicular Lymphoma and Small Lymphocytic Lymphoma

Uncategorized December 9, 2014 at 4:41 PM 0 comments

– Results Describing Long-Term Safety and Disease Control Presented at the 56th American Society of Hematology Annual Meeting – SAN FRANCISCO–(BUSINESS WIRE)–Gilead Sciences, Inc. (NASDAQ: GILD) today announced long-term follow-up results from the registration studies further describing the duration of response, progression-free survival (PFS) and safety profile for Zydelig® (idelalisib) in relapsed patients with chronicRead More

UEG Puts the Need for Better Care for IBD Patients in Europe on the Political Agenda

Uncategorized December 2, 2014 at 4:14 PM 0 comments

(Vienna, 02, December, 2014) With inflammatory bowel disease (IBD) thought to cost the European Community over €2 billion in annual healthcare costs, United European Gastroenterology (UEG) is calling for EU politicians and leading decision-makers to take a more active role in reducing the burden of the disease. Presenting the resultsRead More

Experts Call for Greater Awareness of Alcohol Related Liver Disease and Liver Cancer

Uncategorized November 25, 2014 at 11:29 AM 0 comments

Awareness Week for Alcohol Related Harm 24th – 29th November 2014 Experts call for greater awareness of alcohol related liver disease and liver cancer Vienna, 24 November 2014 – United European Gastroenterology (UEG) is supporting the second annual Awareness Week on Alcohol Related Harm (AWARH) and calls for greater awarenessRead More

High-Dose Interleukin-2 Effective in Metastatic Renal Cell Cancer Pre-Treated with VEGF-Targeted Therapies

Uncategorized November 24, 2014 at 11:37 AM 0 comments

Lugano/Geneva, Switzerland, 24 November 2014 – High-dose interleukin-2 can be effective in selected metastatic renal cell cancer patients pre-treated with VEGF-targeted agents, reveals research presented today at the ESMO Symposium on Immuno-Oncology in Geneva, Switzerland. Lead author Dr Manon Evans, research fellow at the Christie Hospital in Manchester, UK, said:Read More